{"Symbol": "ANAB", "AssetType": "Common Stock", "Name": "AnaptysBio Inc", "Description": "AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company is headquartered in San Diego, California.", "CIK": "1370053", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "10770 WATERIDGE CIRCLE, SAN DIEGO, CA, UNITED STATES, 92121-5801", "OfficialSite": "https://www.anaptysbio.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "1484807000", "EBITDA": "-28102000", "PERatio": "None", "PEGRatio": "0", "BookValue": "-1.067", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-2.82", "RevenuePerShareTTM": "5.76", "ProfitMargin": "-0.499", "OperatingMarginTTM": "0.455", "ReturnOnAssetsTTM": "-0.0423", "ReturnOnEquityTTM": "-3.08", "RevenueTTM": "169467000", "GrossProfitTTM": "16467000", "DilutedEPSTTM": "-2.82", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "1.543", "AnalystTargetPrice": "67.92", "AnalystRatingStrongBuy": "3", "AnalystRatingBuy": "9", "AnalystRatingHold": "1", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "8.76", "PriceToBookRatio": "114.73", "EVToRevenue": "7.29", "EVToEBITDA": "-1.299", "Beta": "0.35", "52WeekHigh": "57.65", "52WeekLow": "13.99", "50DayMovingAverage": "47.6", "200DayMovingAverage": "31.61", "SharesOutstanding": "27688500", "SharesFloat": "15866600", "PercentInsiders": "6.028", "PercentInstitutions": "104.926", "DividendDate": "None", "ExDividendDate": "None"}